Skip to main content

Advertisement

Table 6 Analysis of factors associated with placental malaria by microscopy among delivering women

From: Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania

Variable Placental malaria (PM) Crude OR P-value Adjusted OR P-value
  N No. PM positive (%) (95% CI)   (95% CI)  
Maternal Age   
<20 years 97 42 (43.30) 1.36 (0.86, 2.16) 0.188 1.08 (0.62, 1.89 0.790
≥20 years 334 120 (35.93) Reference   Reference  
Ethnicity       
Sukuma/Zinza 309 122 (39.48) 1.34 (0.86, 2.08) 0.197 1.18 (0.74, 1.89) 0.489
Other Tribes 122 40 (32.79 Reference   Reference  
Health facility
Geita hospital 265 93 (35.09) Reference   Reference  
Katoro HC 166 69 (41.57) 1.32 (0.88, 1.96) 0.177 1.29 (0.84, 1.98) 0.239
Gravidity   
Paucigravidae 227 94 (41.41) 1.41 (0.95, 2.09) 0.084 1.43 (0.89, 2.30) 0.135
Multigravidae 204 68 (33.33) Reference   Reference  
SP receipt   
<3 doses 405 158 (39.01) Reference   Reference  
≥3 doses 26 4 (15.38) 0.28 (0.10, 0.84) 0.023 0.31 (0.10, 0.94) 0.039
Bed net use   
No 10 6 (60.00) 2.48 (0.69, 8.92) 0.165 2.53 (0.69, 9.26) 0.159
Yes 403 152 (37.72) Reference   Reference  
  1. HC = health centre; OR = odds ratio, 95% CI = 95% confidence interval, PM = placental malaria; SP = sulphadoxine-pyrimethamine; Significant p-values are presented in bold.